What does Apotheek Devroe do?

Apotheek Devroe is a pharmacy in Tielt. Private Limited, started on 21 December 1987, 3 establishments.

What is the address of Apotheek Devroe?

The registered office of Apotheek Devroe is located at Kortrijkstraat 129, 8700 Tielt.

Is Apotheek Devroe still active?

Yes. According to the CBE (29 October 2026) Apotheek Devroe is active, legal situation “Normale toestand”, started on 21 December 1987.

Is Apotheek Devroe registered on Peppol?

Yes, Apotheek Devroe is registered on the Peppol network with ID 0208:0432762926.

What is the enterprise number of Apotheek Devroe?

The enterprise number of Apotheek Devroe is BE0432762926.

When was Apotheek Devroe founded?

Apotheek Devroe was founded on 21 December 1987.

Who are the directors of Apotheek Devroe?

According to the 2025 annual accounts, the directors of Apotheek Devroe are: Ruth Devroe.

Is Apotheek Devroe a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 3 establishments in the CBE.

How much profit did Apotheek Devroe make in 2025?

Apotheek Devroe posted a profit after taxes of € 280,689 in financial year 2025.

What is the revenue of Apotheek Devroe?

As a small company, Apotheek Devroe is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,358,364.

How much does an employee at Apotheek Devroe earn?

The average wage cost per full-time employee at Apotheek Devroe was € 67,400 in 2025: staff costs of € 458,169 for 6.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Devroe have?

According to the 2025 annual accounts, Apotheek Devroe has 6.8 full-time equivalents (FTE).

Apotheek Devroe (Private Limited) - Tielt - BE0432762926

Dossier Apotheek Devroe, printed on 29 October 2026 from databakkes.be/en/0432762926/apotheek-devroe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 8.6 to 6.8.

Financials

Financial year 2025

Apotheek Devroe from Tielt, company number BE0432762926, closed financial year 2025 with a result of € 280,689 after tax. For that financial year Apotheek Devroe recorded a gross margin of € 1.4 million and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 399,388 to € 280,689. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What it is worth Growing

€ 1.6 million

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 280,689

▼ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 594,093

▲ 66% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 841 paid out

0 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

6.8

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 458,169

▼ 6% vs 2024

€ 67,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 24,564

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.7 million

▼ 10% vs 2024

€ 164,589 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 278,009

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 177,551

▲ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 997,140 Gross margin 2022: € 997,140 First fiscal year in the series	€ 1,143,269 Gross margin 2023: € 1,143,269 ▲ 15% vs 2022 (€ 997,140) Favourable step	€ 1,282,566 Gross margin 2024: € 1,282,566 ▲ 12% vs 2023 (€ 1,143,269) Favourable step	€ 1,358,364 Gross margin 2025: € 1,358,364 ▲ 6% vs 2024 (€ 1,282,566) Favourable step	▲ 6%
Profit after taxes	€ 247,905 Profit after taxes 2022: € 247,905 First fiscal year in the series	€ 285,588 Profit after taxes 2023: € 285,588 ▲ 15% vs 2022 (€ 247,905) Favourable step	€ 399,388 Profit after taxes 2024: € 399,388 ▲ 40% vs 2023 (€ 285,588) Favourable step	€ 280,689 Profit after taxes 2025: € 280,689 ▼ 30% vs 2024 (€ 399,388) Unfavourable step	▼ 30%
Equity	€ 873,591 Equity 2022: € 873,591 First fiscal year in the series	€ 967,440 Equity 2023: € 967,440 ▲ 11% vs 2022 (€ 873,591) Favourable step	€ 1,365,961 Equity 2024: € 1,365,961 ▲ 41% vs 2023 (€ 967,440) Favourable step	€ 1,645,808 Equity 2025: € 1,645,808 ▲ 20% vs 2024 (€ 1,365,961) Favourable step	▲ 20%
Total debts	€ 2,984,660 Total debts 2022: € 2,984,660 First fiscal year in the series	€ 3,162,060 Total debts 2023: € 3,162,060 ▲ 6% vs 2022 (€ 2,984,660) Unfavourable step	€ 2,865,827 Total debts 2024: € 2,865,827 ▼ 9% vs 2023 (€ 3,162,060) Favourable step	€ 2,647,335 Total debts 2025: € 2,647,335 ▼ 8% vs 2024 (€ 2,865,827) Favourable step	▼ 8%
Cash	€ 659,027 Cash 2022: € 659,027 First fiscal year in the series	€ 291,876 Cash 2023: € 291,876 ▼ 56% vs 2022 (€ 659,027) Unfavourable step	€ 357,177 Cash 2024: € 357,177 ▲ 22% vs 2023 (€ 291,876) Favourable step	€ 594,093 Cash 2025: € 594,093 ▲ 66% vs 2024 (€ 357,177) Favourable step	▲ 66%
Land & buildings	€ 2,213,078 Land & buildings 2022: € 2,213,078 First fiscal year in the series	€ 2,351,918 Land & buildings 2023: € 2,351,918 ▲ 6% vs 2022 (€ 2,213,078) Unchanged	€ 2,269,722 Land & buildings 2024: € 2,269,722 ▼ 3% vs 2023 (€ 2,351,918) Unchanged	€ 2,182,227 Land & buildings 2025: € 2,182,227 ▼ 4% vs 2024 (€ 2,269,722) Unchanged	▼ 4%
Retained profit	€ 850,377 Retained profit 2022: € 850,377 First fiscal year in the series	€ 944,227 Retained profit 2023: € 944,227 ▲ 11% vs 2022 (€ 850,377) Favourable step	€ 1,342,747 Retained profit 2024: € 1,342,747 ▲ 42% vs 2023 (€ 944,227) Favourable step	€ 1,622,595 Retained profit 2025: € 1,622,595 ▲ 21% vs 2024 (€ 1,342,747) Favourable step	▲ 21%
Dividend	€ 808 Dividend 2022: € 808 First fiscal year in the series	€ 191,738 Dividend 2023: € 191,738 ▲ € 190,930 vs 2022 (€ 808) Unchanged	€ 867 Dividend 2024: € 867 ▼ € 190,871 vs 2023 (€ 191,738) Unchanged	€ 841 Dividend 2025: € 841 ▼ 3% vs 2024 (€ 867) Unchanged	▼ 3%
Bank debt	€ 2,544,340 Bank debt 2022: € 2,544,340 First fiscal year in the series	€ 2,212,188 Bank debt 2023: € 2,212,188 ▼ 13% vs 2022 (€ 2,544,340) Favourable step	€ 1,849,834 Bank debt 2024: € 1,849,834 ▼ 16% vs 2023 (€ 2,212,188) Favourable step	€ 1,667,697 Bank debt 2025: € 1,667,697 ▼ 10% vs 2024 (€ 1,849,834) Favourable step	▼ 10%
Balance sheet total	€ 3,858,250 Balance sheet total 2022: € 3,858,250 First fiscal year in the series	€ 4,129,500 Balance sheet total 2023: € 4,129,500 ▲ 7% vs 2022 (€ 3,858,250) Unchanged	€ 4,231,788 Balance sheet total 2024: € 4,231,788 ▲ 2% vs 2023 (€ 4,129,500) Unchanged	€ 4,293,143 Balance sheet total 2025: € 4,293,143 ▲ 1% vs 2024 (€ 4,231,788) Unchanged	▲ 1%
Employees (FTE)	7.4 Employees (FTE) 2022: 7.4 First fiscal year in the series	8.6 Employees (FTE) 2023: 8.6 ▲ 1.2 vs 2022 (7.4) Unchanged	7.4 Employees (FTE) 2024: 7.4 ▼ 1.2 vs 2023 (8.6) Unchanged	6.8 Employees (FTE) 2025: 6.8 ▼ 0.6 vs 2024 (7.4) Unchanged	▼ 0.6

Key figures of Apotheek Devroe, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Devroe?

What happened at Apotheek Devroe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 21, 2026 New annual accounts for financial year 2025: profit of € 280,689 (▼ 30% vs 2024). Source: NBB ↗
2021 Ruth Devroe became a director. NBB
Jan 1, 2011 New establishment in Wingene. KBO
Feb 1, 2009 New establishment in Tielt. KBO
Dec 29, 1987 New establishment in Ardooie. KBO
Dec 21, 1987 Start of the company according to the CBE. KBO

In short

From € 247,905 profit in 2022 to € 280,689 profit in 2025.

Paid € 625,686 in corporate taxes since 2022.

Best year ever: 2024, with € 399,388 profit.

On average € 199,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Ruth Devroe

Apotheek Devroe

WINGENE FARMA

APO-ART

KOOLSKAMP FARMA

Behind Apotheek Devroe is Ruth Devroe. Ruth Devroe is also behind WINGENE FARMA, APO-ART and KOOLSKAMP FARMA.

Directors

According to the 2025 annual accounts

Ruth Devroe

Director

Also active at: WINGENE FARMA, APO-ART, KOOLSKAMP FARMA

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijkstraat 129

8700 Tielt

2.032.143.070

Kloosterstraat 16

8851 Ardooie

Active since 29 December 1987

2.198.215.087

Oude Bruggestraat 48

8750 Wingene

Active since 1 January 2011

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

TAXUS

WINGENE FARMA same network

€ 57,326 gross margin · 2025

KOOLSKAMP FARMA same network

€ 51,640 gross margin · 2025

TIELT FARMA

€ 38,302 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0432.762.926

VAT number

BE 0432.762.926

Registered office

Kortrijkstraat 129, 8700 Tielt

Names & denominations

Apotheek Devroe

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 December 1987

Peppol

Active · Active since 29 Apr 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Devroe

Warning lights

Financials

What happened to Apotheek Devroe?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions